The study involved a clinical trial of 1,509 insured patients following heart attack with a 12-month intervention taking place from 2013 through 2016. For the study, 1,003 patients participated in an intervention involving electronic pill bottles as well as lottery incentives and social support designed to improve medication adherence, while 506 patients received usual care.
Overall, researchers said they found “no statistically significant differences” between the two groups when it came to “time to first rehospitalization for a vascular event or death,” “time to first all-cause rehospitalization,” or “total number of repeated hospitalizations.”
Additionally, the two groups had the same average medication adherence rate and average medical costs following enrollment.
“A compound intervention integrating wireless pill bottles, lottery-based incentives and social support did not significantly improve medication adherence or vascular readmission outcomes for AMI [acute myocardial infarction] survivors,” the study authors concluded.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
